News
-
Trump drug reforms
Wednesday | Feb 14 2018US PRESIDENT Donald Trump has released details of a number of policy reforms aiming to lower medication prices in the USA, but analysts have criticised the measures as "failing to lay a glove on Big Pharma".
-
Pharmacists fined
Wednesday | Feb 14 2018THREE NSW pharmacy owners have been fined $45,000 and ordered to pay more than $67,000 in underpaid entitlements to staff.
-
Superbug killer
Wednesday | Feb 14 2018US SCIENTISTS have discovered a new family of antibiotics in soil samples, according to BBC News.
-
Student survey
Wednesday | Feb 14 2018THE Pharmacy Guild of Australia has launched a survey inviting pharmacy students to have their say on the future of community pharmacy.
-
No sunset on location rule
Wednesday | Feb 14 2018AS A key element of the 2017 Pharmacy Compact, the National Health Amendment passed by the Senate yesterday abolishes the sunset clause of the Location Rules, ensuring that the rules do not automatically expire at the end of the Sixth Community Pharmacy Agreement (6CPA) in Jun 2020.
-
Eagle Health diabetes wins
Wednesday | Feb 14 2018ASX-LISTED Eagle Health has outlined ambitious plans to further boost its presence in China, building on the success of its "Hutang 1" Australian pre-meal shake product for Type 2 diabetes and Pre-Type 2 diabetes in the Chinese market.
-
Webstercare cuts 6CPA red tape
Wednesday | Feb 14 2018TO MEET the needs of pharmacists complying with the increased Sixth Community Pharmacy Agreement (6CPA) dose administration (DAA) funding reporting requirements, effective 01 Feb, Webstercare has announced its Medication Management Software (MMS) system offers a solution that cuts the administrative red tape.
-
Dispensary Corner 13 Feb 18
Tuesday | Feb 13 2018IN WHAT has been described as US President Donald Trump's Marilyn Monroe moment, a gust of wind has sent the world's plastic surgeons into a collective tizzy as wisps of Trump's hair recently parted to reveal what some suspect is a surgical scar.
-
Proteomics deal
Tuesday | Feb 13 2018ASX-LISTED clinical trials firm Proteomics International has announced a new strategic alliance with CPR Pharma Services, with a share swap deal which will see Proteomics acquire 10% of CPR.